In-vitro activity of FK 037 (Cefoselis), a novel 4th generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates

Diagnostic Microbiology and Infectious Disease

Volumn 36, Issue 3, 2000, Pages 185-191

  Giamarellos Bourboulis, E J ^a,b   Grecka, P ^b   Tsitsika, A ^b   Tympanidou, C ^b   Giamarellou, H ^b  

^a Department of Propaedeutic Medicine ^*  (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFEPIME; CEFOSELIS; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; PIPERACILLIN; RIFAMPICIN; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ACINETOBACTER; CEFTIZOXIME; CEPHALOSPORINS; CROSS INFECTION; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIA; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS;

EID: 0034071147     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00131-5     Document Type: Article

References (14)

1. Ardanuy C., Linares J., Dominguez M.A., Hernandez-Alles S., Beneti V.J., Martinez-Martinez L. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob Agents Chemother. 42:1998;1636-1640.
2. Climo M.W., Markowitz S.M., Williams D.S., Hale-Cooper C.G., Archer G.L. Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species. J Antimicrob Chemother. 40:1997;59-66.
3. Elkhaili H., Kamili N., Linger L., Leveque D., Pompei D., Monteil H., Jehl F. In vitro time-kill curves of cefepime and cefpirome combined with amikacin, gentamicin, or ciprofloxacin against Klebsiella pneumoniae producing extended-spectrum β-lactamases. Chemotherapy. 43:1997;245-253.
4. Elkaili H., Pompei D., Peter J.D., Linger L., Salmon J., Levêque D., Niedergang S., Salmon Y., Thierry R.C., Monteil H., Jehl F. Pharmacocinétique de l'amikacine in vivo et sa pharmacodynamie en association avec le céfépime, cefpirome et méropénème dans un modèle in vitro/in vivo de microporc. Pathologie Biologie Mai. 1997;347-356.
5. Giamarellos-Bourboulis E.J., Grecka P., Giamarellou H. In-vitro interactions of DX-8739, a new carbapenem, meropenem, and imipenem with amikacin against multiresistant Pseudomonas aeruginosa. J Antimicrob Chemother. 38:1996;287-291.
6. Giamarellou H. Clinical experience with the fourth generation cephalosporins. J Chemother. 8:(suppl 2):1996;91-104.
7. Hindler, J (1992) Tests to detect oxacillin (methicillin) resistant staphylococci with an oxacillin screen plate. In: Clinical Microbiology Procedures Handbook. Ed, Eisenberg HD. Washington, DC: American Society for Microbiology, pp. 5.5.1-5.5.7.
8. Hindler, J (1992) Tests to assess bactericidal activity. In: Clinical Microbiology Procedures Handbook. Ed, Eisenberg HD. Washington, DC: American Society for Microbiology, pp. 5.16.14- 5.16.24.
9. Laws A., Page M. The chemistry and structure-activity relationships of C3-quarternary ammonium cephem antibiotics. J Chemother. 8:(suppl. 2):1996;7-22.
10. Mine Y., Watanabe Y., Sakamoto H., Hatano K., Higashi Y., Kamimura T., Matsumoto Y., Tawara S. In vitro antibacterial activity of FK 037, a novel parenteral broad-spectrum cephalosporin. J Antibiot. 46:1993;71-87.
11. Mine Y., Watanabe Y., Sakamoto H., Hatano K., Higashi Y., Kamimura T., Tawara S., Matsumoto S. In vivo antibacterial activity of FK 037, a novel parenteral broad-spectrum cephalosporin. J Antibiot. 46:1993;88-98.
12. Minoz O., Jacolot A., Padoin C., Caillon J., Louchahi K., Tod M., Samili K., Petitjean O. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. J Antimicrob Chemother. 39:1997;363-369.
13. Peformance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement (1999). Vol, 19.
14. th Ed. (pp. 1327-1341). Washington, DC: American Society for Microbiology.